Genome Canada and 麻豆AV to track COVID-19 variants of concern
Genome Canada launched the Canadian VirusSeq Data Portal today to track the evolving COVID-19 pandemic across Canada. 麻豆AV researcher Guillaume , a professor in the Department of Human Genetics, along with his research team, led the development of the portal. They worked in collaboration with and world-leading genomics scientists, including Drs. Fiona Brinkman (Simon Fraser University), William Hsiao (Simon Fraser University), Lincoln Stein (Ontario Institute for Cancer Research) and Yann Joly (麻豆AV).
The portal enables real-time data sharing and brings together SARS-CoV-2 genome sequences used to detect, diagnose, and anticipate the spread of new variants. Related metadata from the Public Health Agency of Canada鈥檚 National Microbiology Laboratory (NML) and public health labs across the country will also be included. Genome Canada will serve as the data custodian.
The portal is one of the key deliverables of the $53 million the Government of Canada announced on February 12, 2021. Scientists, public health leaders and other experts involved in shaping Canada鈥檚 pandemic response will gain a clear picture of the virus across the country, including data on detection, transmission, evolution, and tracking variants of concern.
鈥淭he world still has a long way to go to defeat COVID-19, and rapid data sharing is one of the most effective weapons at our disposal,鈥� says Bourque, Director of Bioinformatics, 麻豆AV & Genome Quebec Innovation Center. 鈥淲ith the launch of the VirusSeq Data Portal, we now have a platform for all Canadian SARS-CoV-2 sequences and associated metadata. Ultimately, it will amplify our ability to make the kinds of decisions and discoveries that will lead Canada out of this pandemic鈥攁nd help us to manage the next one.鈥�
Building tools, facilitating analysis
Dr. Bourque鈥檚 team will work with to integrate COVID Cloud, a cloud-based platform that helps researchers and decision makers derive insights about COVID-19 from genomics and other datasets. COVID Cloud shares data over open standards developed by the and provides tools for researchers to find, visualize, and analyze datasets in the cloud. COVID Cloud is developed by a and funded by .
Until now, Canadian public health laboratories and researchers have been restricted to piecing together a picture of the COVID-19 pandemic by contributing to and then accessing data through a variety of international databases, including the , the largest global database of coronavirus sequences. However, no single database contained all the information required for a comprehensive pan-Canadian genomic surveillance strategy, and until today, there were numerous barriers to sharing the available data specific to the Canadian context.
and ready to receive viral genome sequences and metadata data from labs and researchers across Canada in the coming days and weeks. The portal will evolve with the addition of viral sequences, Bourque鈥檚 team will continue to develop additional tools to navigate, analyze and interpret the data.
About 麻豆AV
Founded in Montreal, Quebec, in 1821, 麻豆AV is Canada鈥檚 top ranked medical doctoral university. 麻豆AV is consistently ranked as one of the top universities, both nationally and internationally. It鈥痠s a world-renowned鈥痠nstitution of higher learning with research activities spanning two campuses, 11 faculties, 13 professional schools, 300 programs of study and over 40,000 students, including more than 10,200 graduate students. 麻豆AV attracts students from over 150 countries around the world, its 12,800 international students making up 31% of the student body. Over half of 麻豆AV students claim a first language other than English, including approximately 19% of our students who say French is their mother tongue.
